Literature DB >> 6712002

Presence of aminoglycoside acetyltransferase and plasmids in Mycobacterium fortuitum. Lack of correlation with intrinsic aminoglycoside resistance.

S I Hull, R J Wallace, D G Bobey, K E Price, R A Goodhines, J M Swenson, V A Silcox.   

Abstract

Isolates of the 3 biovariants of Mycobacterium fortuitum exhibited 3 patterns of resistance when tested against 9 aminoglycosides. Examination of cell lysates from the 3 groups revealed 15/15 isolates to contain an aminoglycoside acetyltransferase (AAC) resembling AAC (3)-III or (3)-IV found in bacterial species. The enzyme did not appear to confer resistance, as its activity did not correlate with any pattern of resistance. The DNA extraction revealed plasmids in only 2 of 8 isolates tested, suggesting no relationship of plasmids to intrinsic aminoglycoside resistance or the presence of the AAC. These studies, combined with current knowledge of ribosomal resistance, suggest altered cellular transport or permeability as the mechanism of intrinsic aminoglycoside resistance in this species, although the patterns of resistance are different from those observed in other bacteria with nonenzymatic aminoglycoside resistance. This is the first demonstration of specific aminoglycoside-modifying enzymes among mycobacterial species and the first report of plasmids in M. fortuitum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712002

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  10 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  Isolation by genetic labeling of a new mycobacterial plasmid, pJAZ38, from Mycobacterium fortuitum.

Authors:  J A Gavigan; J A Aínsa; E Pérez; I Otal; C Martín
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

Review 3.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Characterization of large linear plasmids in mycobacteria.

Authors:  M Picardeau; V Vincent
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

5.  Mycobactin analysis as an aid for the identification of Mycobacterium fortuitum and Mycobacterium chelonae subspecies.

Authors:  S Bosne; V V Lévy-Frébault
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

6.  Characterization of the chromosomal aminoglycoside 2'-N-acetyltransferase gene from Mycobacterium fortuitum.

Authors:  J A Aínsa; C Martin; B Gicquel; R Gomez-Lus
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

7.  Susceptibilities of Mycobacterium fortuitum biovariant fortuitum and the unnamed third biovariant complex to heavy-metal salts.

Authors:  R J Wallace; L C Steele; G D Forrester; J M Swenson; S I Hull
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

8.  Aminoglycoside resistance in Mycobacterium kansasii, Mycobacterium avium-M. intracellulare, and Mycobacterium fortuitum: are aminoglycoside-modifying enzymes responsible?

Authors:  I I Ho; C Y Chan; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

9.  Tetracycline resistance determinants in Mycobacterium and Streptomyces species.

Authors:  Y Pang; B A Brown; V A Steingrube; R J Wallace; M C Roberts
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

10.  Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates.

Authors:  Su-Young Kim; Dae Hun Kim; Seong Mi Moon; Ju Yeun Song; Hee Jae Huh; Nam Yong Lee; Sung Jae Shin; Won-Jung Koh; Byung Woo Jhun
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.